Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Fri, 19.01.2024
North Peak Resources Ltd.
Calgary, Alberta--(Newsfile Corp. - January 19, 2024) - North Peak Resources Ltd. (TSXV: NPR) (the "Company" or "North Peak") reports that it has drilled its first deep core hole at Prospect Mountain (the "Property") and that a BHEM survey is being undertaken to identify potential locations for further wedge drilling. This first hole NPR23-01 in Ph [ … ]
Fri, 19.01.2024
BayWa AG
BayWa Supervisory Board Chairman resigns from office
BayWa Aktiengesellschaft
Public disclosure of inside information in accordance with Art. 17 MAR
Munich, 19 January 2024:
The Chairman of the BayWa Supervisory Board, Prof Klaus Josef Lutz, has today resigned from his office as a member of the Supervisory Board with immediate effec [ … ]
Fri, 19.01.2024
P2X-Europe GmbH & Co. KG
Press Release
Hamburg | 19 January 2024
The Breogan project, promoted by P2X-Europe and Greenalia,
declared a Priority Business Initiative (PBI) by the Xunta de Galicia
Project Bregoan was declared a Priority Business Initiative by the Xunta de Galicia for the alignment with the government’s strategic and sustainability goals.
Th [ … ]
Fri, 19.01.2024
Blue Cap AG
Munich, January 19, 2024 – Blue Cap AG (“Blue Cap”) expects better earnings for the 2023 financial year than last assumed. According to initial preliminary calculations as part of the ongoing preparation of the consolidated financial statements for the 2023 financial year, the Blue Cap management board assumes an adjusted(1) EBITDA margin for conti [ … ]
Fri, 19.01.2024
P&P Group
Fürth/London/Munich 19 January 2024 - The German property developer P&P Group and its sister companies, the British developer P&P London and Rivus Capital achieved excellent financial results in 2023. The companies are operating under the leadership of founder and investor Michael Peter. In Germany, property development is focused primarily [ … ]
Fri, 19.01.2024
AT&S Austria Technologie & Systemtechnik AG
AT&S corrects revenue forecast for the current financial year 2023/24
Disclosure of inside information pursuant to Article 17 MAR
Leoben – AT & S Austria Technologie & Systemtechnik Aktiengesellschaft has adjusted its revenue forecast for the current financial year 2023/24 due to lower demand caused by high inventory levels, [ … ]
Fri, 19.01.2024
Mutares SE & Co. KGaA
Mutares places second tap issue of its bond issued in March 2023 with a volume of EUR 100 million and strengthens basis for further development
Successful capital market transaction thanks to optimal market conditions
Investors convinced by Mutares' attractive transaction pipeline and track record
Strengthening further growth opportunities for M [ … ]
Fri, 19.01.2024
Mutares SE & Co. KGaA
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, INTO OR IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER COUNTRY IN WHICH SUCH DISTRIBUTION OR PUBLICATION MAY BE UNLAWFUL. FURTHER RESTRICTIONS APPLY. PLEASE [ … ]
Fri, 19.01.2024
Hardman & Co Research
Analyst interview | Investment Companies
Q&A on ICG Enterprise Trust (ICGT) | Analysing the risk and reward opportunity for investors
ICG Enterprise Trust (ICGT) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co, joins DirectorsTalk Interviews.
In this interview, Mark discusses his recent report entitled 'Putting th [ … ]
Fri, 19.01.2024
Cardiol Therapeutics Inc
First Berlin Equity Research has published a research update on Cardiol
Therapeutics Inc. (ISIN: CA14161Y2006). Analyst Christian Orquera
reiterated his BUY rating and maintained his USD 3.60 price target.
Abstract:
Cardiol Therapeutics (Cardiol) has completed >50% of patient recruitment
for CardiolRx's two lead indications, acute myocarditi [ … ]